Seven digit investment for Lymphatica

Please login or
register
03.12.2020
Lymphatica Team

Lymphatica developed LymphoDRAIN, an implantable device for the treatment of chronic lymphedema. Thanks to the receipt of a seven-digit investment, the company will enter the clinical development and validation phase.

More than 100 million people struggle with lymphedema worldwide, yet there is still no effective treatment against it. Lymphatica Medtech SA, a spinoff from the EPFL and the Lausanne University Hospital (CHUV - Centre Hospitalier Universitaire Vaudois, fills this gap with LymphoDRAIN, the world’s first implantable device for the treatment of chronic lymphedema. The solution will allow physicians to effectively treat their patients, significantly reduce the patient need for performing manual drainage therapy and wearing compression garments.

The company has obtained fresh capital in an investment round led by High Tech Gründerfonds. Business angels, the EIT Health (European Institute of Innovation and Technology) and existing investors, including LIVEventures, also participated in the round. The funds will allow the startup to start the clinical development and validation of its device. Thanks to the Start-up Rescue Instrument from the EIT Health, Lymphatica will also improve its device connectivity through mobile apps.

“The new investment will allow us to proceed in our development plan, focusing on gathering the necessary clinical evidence to accelerate our path to market. We are proud to have experienced investors on board, sharing our vision”, says Marco Pisano, CEO and co-founder.

Anke Caßing, Senior Investment Manager at High-Tech Gründerfonds said: “We were particularly impressed with the team’s structured approach to the development of a much-needed treatment innovation in lymphedema. We are pleased to accompany and support Lymphatica on their way forward.”

In line with the announcement, the company has welcomed Laurent Duhoux (ex VP New Technology at Edwards Lifesciences) to its Board of Directors.

(Press release/RAN)

0Comments

More news about

Lymphatica Medtech SA

Company profiles on startup.ch

Lymphatica Medtech SA

rss